Spine surgeons are confronting a growing disconnect between procedures they believe are performed too often and those patients struggle to access. While some warn that unnecessary fusions and surgeries driven by imaging findings remain common, others say rigid insurer requirements are delaying appropriate care for patients with clear surgical indications.
Here is where seven spine surgeons believe the specialty is overtreating patients, and where payer restrictions are creating barriers to necessary surgery.
Ask Spine Surgeons is a weekly series of questions posed to spine surgeons around the country about clinical, business and policy issues affecting spine care. Becker’s invites all spine surgeon and specialist responses.
Next question: What is one technically possible spine operation that you increasingly believe surgeons should be more willing to walk away from?
Please send responses to Sophie Eydis at seydis@beckershealthcare.com by 5 p.m. Central time Sunday, Nov. 22.
Editor’s note: Responses have been lightly edited for clarity and length.
Question: Where do you think spine surgery is still overtreating patients, and where are payers now making appropriate surgery unnecessarily difficult to justify?
Bryce Basques, MD. Spine Surgeon and Director of Minimally Invasive and Endoscopic Spine Surgery at Brown University (Providence, R.I.): I genuinely think overtreatment usually happens because surgeons are afraid to leave residual pathology that could lead to poor outcomes or early reoperation. As a field, we haven’t yet figured out the perfect surgery for each patient because every spine is unique, and there are so many variables to consider when planning a surgery. Two patients with the same MRI may need completely different surgical approaches based on their goals, comorbidities and psychology. Unfortunately, payers try to treat all spine patients the same with rigid diagnostic and treatment criteria, with no allowance for physician judgment.
Samuel Joseph Jr., MD. Founder of Joseph Spine Institute (Tampa Bay, Fla.): I believe spine surgery still overtreats patients when decisions are driven more by MRI findings than by symptoms, clinical examination, and functional limitations. Not every disc herniation or case of spinal stenosis requires surgery. We also need to be more selective about spinal fusion when a less invasive, motion-preserving procedure can achieve the same clinical goal.
On the other hand, insurance companies sometimes make appropriate surgery unnecessarily difficult to justify. Outdated treatment guidelines, rigid conservative-care requirements, and repeated prior authorization delays can prevent patients from accessing procedures that are supported by their clinical condition and current surgical advances. This is particularly true with minimally invasive and endoscopic spine surgery.
Ultimately, we need balance. Surgeons should avoid unnecessary procedures, but payers must recognize when surgery is medically appropriate. We should never operate simply because we can, but we should never prevent a patient from receiving the right operation when it is medically necessary. It’s about getting the right procedure to the right patient at the right time.
Issada Thongtrangan, MD. Endoscopic and Minimally Invasive Spine Surgeon at MicroSpine (Scottsdale, Ariz.): We are still overtreating mostly fusion for axial low back pain without radiculopathy or instability. Degenerative disc disease, multilevel degenerative changes and low-grade stable spondylolisthesis. A lot of that still gets a big fusion when decompression alone, or non-operative care, would do. The recent randomized controlled trials on stenosis with grade 1 spondylolisthesis showed decompression alone is often non-inferior to adding fusion. We’re also still fusing too many levels for stenosis when only one level is truly unstable.
Payers can make it difficult for patients to access appropriate spine surgery. The flip side is patients with classic single-level disc herniation and persistent radiculopathy, or central stenosis with neurogenic claudication and clear imaging correlation. Those patients get stuck in six to 12 months of mandated physical therapy, injections, step therapy and prior authorization loops even when they’ve failed reasonable conservative care or have progressive deficits. Also motion preservation, like lumbar disc replacement in a young, well-selected patient, is evidence-supported but often denied as “experimental,” so the only covered option is fusion.
In short, we over-fuse stable spines for pain, and we under-approve straightforward decompressions and targeted fusions for nerve compression where surgery actually works well.
David Weiner, MD. Assistant Professor at Georgetown University Medical School (Washington, D.C.) and Orthopedic Spine Surgeon at MedStar Health (Columbia, Md.): We risk overtreatment when we operate on an MRI rather than on a patient, especially when surgery expands to levels with no convincing link to the symptoms. At the same time, payers can make an appropriate operation unnecessarily difficult when a patient has a concordant neurologic problem, meaningful functional loss and a reasonable course of nonoperative care, yet authorization hinges on a rigid checklist. Careful indication setting and fair access are complementary: We should be willing to say no to low-value surgery and equally willing to defend a well-supported operation.
Nolan Wessell, MD. Assistant Professor of Orthopedic Surgery at University of Colorado Anschutz School of Medicine (Aurora, Colo.): We’ve seen the pendulum swing in the direction of deformity correction surgery. In the right setting, these are incredibly valuable procedures. However, in some circumstances, a larger lumbar decompression may be all that’s necessary, particularly in older individuals. Personally, I think it’s time to re-evaluate how payers value CPT 63047 and 63048. Laminectomy and decompression can be life changing for older individuals who hope to remain active. Decompression surgery has a high profit margin for the facility or health system; professional reimbursement has declined to a point where these procedures are becoming a less efficient use of the surgeon’s time. We should re-think how we value procedures that are effective, reproducible, carry a low risk of complication and a very high rate of patient satisfaction.
Jacky Yeung, MD. Neurosurgeon at Hartford (Conn.) Healthcare Ayer Neuroscience Institute: I think we still overtreat patients when axial pain is assumed to come from the spine simply because imaging shows degeneration. A significant portion of pain can be myofascial, muscular, or referred, and surgery will not fix the wrong pain generator. On the other side, payers can make appropriate surgery unnecessarily difficult when they rely too heavily on imaging thresholds or rigid algorithms instead of the full clinical picture.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
